NEW ORLEANS — In the PULSED AF pivotal trial, pulsed field ablation of symptomatic atrial fibrillation yielded a low rate of adverse events and demonstrated effectiveness consistent with established ablation strategies at 1 year.Pulsed field ablation is a novel ablation technology that utilizes electrical pulses to treat AF.